Health Canada is updating the labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
Critical priority
What you should do
- 1If you have received the Janssen or Vaxzevria COVID-19 vaccine:Seek prompt medical attention immediately if you have any of the following symptoms after vaccination:unexplained bleedingunexplained bruisingsmall purplish spots beyond the site of vaccination shortness of breathchest painleg pain and/or swellingpersistent abdominal painTalk to your healthcare professional if you have any questions about the Janssen or Vaxzevria COVID-19 vaccines.
- 2Report any adverse events after immunization to your healthcare professional.
- 3If you are a healthcare professional:Be alert to the signs and symptoms of thromboembolism and thrombocytopenia to promptly treat these conditions according to available evidence and clinical guidelines.
- 4Inform people receiving the vaccine to seek medical attention if they develop any of the following symptoms:ITP symptoms include spontaneous bleeding, unusual bruising or small red, purple or brown spots that appear under the skin.
- 5VTE symptoms include shortness of breath, chest pain, leg pain, leg swelling, or persistent abdominal pain following vaccination.
The issue
Product safety - COVID
Affected product
Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.